Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • M&A
  • Markets
  • News

RIV Capital Completes Final Closing Of Etain Acquisition

By Vuk Zdinjak
December 16, 11:29 AM
RIV Capital Inc.

CNPOF

Read More
2 minute read
  • Cannabis
  • Dividends
  • Markets
  • News

Chicago Atlantic Real Estate Finance Declares Dividend For Q4 2022

By Vuk Zdinjak
December 16, 11:16 AM
Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash dividend of $0.47 per share for the fourth quarter of 2022.

REFI

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Offerings
  • Penny Stocks

Agrify Stock Plunges On Pricing $8.7M Public Offering

By Nina Zdinjak
December 16, 10:53 AM
Agrify Corporation (NASDAQ: AGFY) announced the pricing of its underwritten public offering of (I) around 11.88 million common shares, and, in lieu of common stock to certain investors that so chose, pre-funded warrants to buy 1.5 million shares of its c

AGFY

Read More
2 minute read
  • Cannabis
  • M&A
  • Markets
  • News
  • Penny Stocks

ADHC To Acquire Cannabis Firm & Amazon Vendor Rolls Choice

By Nina Zdinjak
December 16, 9:57 AM
American Diversified Holdings Corporation (OTC: ADHC) confirmed Friday it has reached an agreement to acquire Rolls Choice, a southern California-based cannabis firm, and an Amazon (NASDAQ: AMZN) vendor.

ADHC

Read More
2 minute read
  • Cannabis
  • Exclusives
  • Markets
  • News
  • Penny Stocks
  • Retail Sales

Exclusive: 4Front Expands Its Product Portfolio In Massachusetts Ahead Of Holiday Season

By Jelena Martinovic
December 16, 8:35 AM
4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) is expanding its Island Cannabis Co.

CSE:FFNT

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories

It’s Not Just Trulieve: Multiple Cannabis Companies Confirm Layoffs, Turbulent EOY

By Nicolas Jose Rodriguez
December 15, 5:50 PM
Cannabis company Trulieve Inc. (OTCQX: TCNNF) has reportedly laid off an unspecified number of employees at its

ACB

Read More
2 minute read
  • Cannabis
  • FDA
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

FDA OKs Ketamine For Treating Organ Transplant Injuries With ‘Orphan Drug’ Status

By Lara Goldstein
December 15, 3:12 PM
The U.S. Food and Drug Administration (FDA) has granted PharmaTher Holdings Ltd. (OTCQB: PHRRF) an Orphan Drug designation for ketamine in the prevention of injury from organ transplantation.

PHRRF

Read More
1 minute read
  • Cannabis
  • Contracts
  • Markets
  • News
  • Offerings
  • Penny Stocks
  • Psychedelics
  • Top Stories

Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU

By Lara Goldstein
December 15, 2:38 PM
Filament Health Corp. (OTCQB: FLHLF) and Psyence Group Inc. (OTCQB: PSYGF) have inked a worldwide commercial licensing deal.

FLHLF

Read More
3 minute read
  • Cannabis
  • Exclusives
  • FDA
  • General
  • Global
  • Guidance
  • Health Care
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap
  • Top Stories

EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans

By Lara Goldstein
December 15, 1:48 PM
Part one of a three-part series. The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.

AGNPF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

High Tide’s FAB CBD To Donate Portion Of Every Sale To The Dream Machine’s Children’s Cancer Initiative

By Vuk Zdinjak
December 15, 12:31 PM
FAB CBD, a subsidiary of High Tide Inc. (NASDAQ: HITI) announced its holiday sale. The sale begins on December 15, and runs through January 2, 2023.

HITI

Posts pagination

Previous 1 … 336 337 338 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service